DDrare: Database of Drug Development for Rare Diseases

Other: surgery (DrugBank: -)

2 diseases

ID	Disease name (Link within this page)	Number of trials
74	Prolactin secreting pituitary adenoma	1
96	Crohn disease	1

74. Prolactin secreting pituitary adenoma [ 18 clinical trials, 33 drugs, (DrugBank: 10 drugs), 16 drug target genes, 63 drug target pathways]

Searched query = "Prolactin secreting pituitary adenoma", "Pituitary PRL secretion hyperthyroidism", "Prolactinoma", "Prolactin secreting adenoma"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 18 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03717454 (ClinicalTrials.gov)	December 1, 2018	14/10/2018	Dopamine D2 Receptors(D2R) Imaging in Prolactinomas	The Predictive Value of Positron Emission Tomography-Magnetic Resonance (PET-MR) Mediated Dopamine D2 Receptors Imaging in the Drug Therapy of of Prolactinomas.	Prolactinoma	Other: Surgery;Drug: Drug treatment	Zhebao Wu	Xinqiao Hospital of Chongqing;First Hospital of China Medical University;Beijing Tiantan Hospital;First Affiliated Hospital of Wenzhou Medical University;First Affiliated Hospital of Fujian Medical University;Peking Union Medical College Hospital;Huashan Hospital;Chinese PLA General Hospital	Not yet recruiting	18 Years	65 Years	All	50	N/A	NULL

96. Crohn disease [ 2,209 clinical trials, 1,276 drugs, (DrugBank: 240 drugs), 166 drug target genes, 210 drug target pathways]

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,209 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01540942 (ClinicalTrials.gov)	November 2011	23/2/2012	Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease	A Randomized, Controlled, Open-label Study to Investigate the Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease	Crohn's Disease	Dietary Supplement: nutrition treat;Other: surgery	Jinling Hospital, China	NULL	Completed	18 Years	75 Years	Both	91	N/A	China